2D Echo | Angio | ECG | X-Ray/MRI | Clinical Trials | Guidelines | Drug Info |  Journals  | Events | Interesting Cases
Welcome Sep 3, 2010
Search News by Date
  
          
 C V   N E W S C E N T E R
Updated:  Sep 3, 2010
Atorvastatin therapy reduces the risk of developing arrhythmias in patients with HF with preserved systolic function
To investigate the complex effect of atorvastatin in patients (pts) with arrhythmias and heart failure (HF) with preserved systolic function of ischemic etiology. 
Overweight/obesity negatively influences the effectiveness of the pharmacological treatment of the primary arterial hypertension in children
Aim of the study was evaluation of influence of obesity on the severity of primary arterial hypertension (PHA) and its pharmacological treatment in children.
Prolonging enoxaparin therapy to one month restores blood flow in patients with venous thromboembolism
To assess whether the prolongation of initial enoxaparin (En) therapy to one month could improve the restoration of venous blood flow and 1-year outcomes in pts with DVT/PE.
Increasing clopidogrel maintenance dose to 150 mg/day significantly improves mean platelet inhibition, in low-responsive patient
To examine the effect of genetic polymorphisms on platelet response to the 150 mg of Clopidogrel in low-responders receiving 75 mg Clopidogrel therapies.
• Atorvastatin therapy reduces the risk of developing arrhythmias in patients with HF with preserved systolic function  • Impact of adding cilostazol or clopidogrel to standard aspirin and clopidogrel treatment in T2DM patients and coronay artery disease undergoing percutaneous coronary intervention  • Effect of a single high loading dose of rosuvastatin on peri-procedural myocardial injury in statin-naive patients with stable angina  • Rosuvastatin exhibits long term beneficial vascular effects in hypertensive patients with dyslipidemia  • Angiotensin II type-1 receptor antagonist telmisartan effects on endothelial activation induced by advanced glycation endproducts  • Heart and Soul Study: Association of blood pressure and heart rate response during exercise with cardiovascular events in patients with CAD  • Prognostic value of Type D personality in patients with chronic heart failure  
 REVIEWS
 
Review on Angiotensin receptor blockade and risk of cancer meta-analysis published in Lancet oncology
In the June issue of the Journal, Lancet Oncol 2010; Sipahi et al provide hypothesis that angiotensin receptor blockers (ARBs) are associated with a modestly increased risk of new cancer diagnosis based on the results of a meta-analysis.
Impact of Blood Pressure Variability on Cardiovascular Outcomes
Cardiorenal Syndrome - a dipole with many inter-relationships
Transcatheter Aortic Valve Implantation – a credible alternative to open heart surgery
Aliskiren – The Elixir for Hypertension
ETIOPATHOGENESIS AND MANAGEMENT OF ATRIAL FIBRILLATION: A REVIEW

 INDUSTRY NEWS

CHMP gives a positive opinion for a new indication for GSK’s Arixtra

ACC/AHA Release Clinical Alert In Response To FDA Boxed Warning About Anti-Platelet Agent, Clopidogrel

Biospherics acquires global patent rights to develop Tagatose as a trigylcerides therapy
  More..
 INTERESTING  CASES
 
A 5 year old boy was brought to the pediatric unit of our hospital with complaints of fatigue, shortness of breath and recurrent upper respiratory tract infections.
These problems may include pulmonary hypertension, congestive heart failure, atrial arrhythmias and an increased risk of stroke

 ECG  QUIZ
 
Understanding Electrical Activity. The following ECG is recorded.
Previous Quiz Results    Previous Quiz

 COMING   EVENTS
 
TCT 2010
September 21, 2010 - September 25, 2010
Washington

E-mail/Website:
Go to Top
  
Levels of myeloperoxidase are decreased at the culprit coronary lesion before PCI, in patients presenting early with STEMI
 
True False
Not Sure
 
Related Article
 
 
About Us | Disclaimer |  Privacy Statement | Advertising Info 
info@centrixhealthcare.com © Copyright 2000-2010 Centrix Healthcare Inc. - All Rights Reserved.